SOURCE: Vanguard Health Systems, Inc.

September 18, 2007 16:22 ET

Vanguard Reports Fourth Quarter and Year-End Results

NASHVILLE, TN--(Marketwire - September 18, 2007) - Vanguard Health Systems, Inc. ("Vanguard") today announced results for the fourth quarter and fiscal year ended June 30, 2007.

Total revenues for the quarter ended June 30, 2007 were $651.1 million, an increase of $29.3 million or 4.7% from the prior year quarter. Patient service revenues increased $24.8 million from the prior year quarter. Health plan premium revenues increased $4.5 million from the prior year quarter. The quarter over quarter increase in patient service revenues was attributable to a 1.6% increase in hospital adjusted discharges from continuing operations and a 5.0% increase in patient revenue per adjusted hospital discharge from continuing operations during the current year quarter compared to the prior year quarter. While patient volumes increased modestly quarter over quarter, Vanguard's revenue growth during the current year quarter was limited by a payer mix shift from Medicare and commercial revenues to managed care and self-pay revenues in certain of our markets compared to the prior year quarter.

Vanguard reported a $5.6 million loss from continuing operations for the current year quarter compared to a $2.5 million loss from continuing operations during the prior year quarter. Salaries and benefits as a percentage of total revenues increased to 41.7% during the current year quarter compared to 40.8% during the prior year quarter. Hospital-employed full time equivalents increased 4.4% quarter over quarter due to our efforts to staff new service lines at certain of our Arizona and San Antonio hospitals and to establish the infrastructure for our quality initiatives. Provision for doubtful accounts as a percentage of total revenues increased to 7.0% during the current year quarter compared to 6.0% during the prior year quarter. Self-pay revenues as a percentage of net patient revenues increased to 10.5% during the current year quarter compared to 8.7% during the prior year quarter, while self-pay discharges from continuing operations as a percentage of total discharges from continuing operations increased to 3.5% from 3.0% quarter over quarter.

Purchased services as a percentage of total revenues improved from 5.7% to 4.9% quarter over quarter primarily as a result of reductions in medical specialist fees and legal fees. Other operating expenses as a percentage of total revenues improved from 8.7% to 7.6% quarter over quarter primarily as a result of improved historical claims experience in our self-insured malpractice program and lower retrospectively rated premiums for our malpractice excess coverage.

During the current year quarter, Vanguard's net loss was $9.6 million compared to a $13.6 million net loss during the prior year quarter. The decrease was primarily due to the decrease in quarter over quarter loss from discontinued operations, net of taxes.

Quarter over quarter Adjusted EBITDA was flat at $58.2 million. A reconciliation of Adjusted EBITDA to net loss as determined in accordance with generally accepted accounting principles for the quarters ended June 30, 2006 and 2007 is included in the attached supplemental financial information.

The consolidated operating results for the current year quarter reflect a 2.0% increase in discharges from continuing operations and a 1.6% increase in hospital adjusted discharges from continuing operations compared to the prior year quarter. The increase in quarter over quarter discharges from continuing operations is primarily attributable to the increased patient volumes at those San Antonio and Phoenix hospitals in which we recently completed projects to expand services and bed capacity. Demand for higher acuity services and elective procedures in our markets remains weak, and competition for these services continues to increase. Emergency room visits from continuing operations increased by 3.0% quarter over quarter, while outpatient surgeries from continuing operations declined slightly.

Total revenues for the year ended June 30, 2007 were $2,580.7 million, an increase of $162.1 million or 6.7% from the prior year period. Patient service revenues and health plan premium revenues increased $135.7 million and $26.4 million, respectively, from the prior year period. Total revenues during the current year period were positively impacted by period over period increases in hospital adjusted discharges from continuing operations, patient revenue per hospital adjusted discharge from continuing operations and emergency room visits from continuing operations and the impact of having a full twelve months of operations of Vanguard's Medicare Advantage Plan in Arizona during the current year period.

Vanguard reported a loss from continuing operations of $113.6 million during the current year period compared to income from continuing operations of $23.5 million during the prior year period. The current year period loss from continuing operations is primarily attributable to the $123.8 million ($110.5 million, net of tax benefit) impairment charge recorded during December 2006 to write down goodwill related to Vanguard's Chicago hospitals to fair value as previously disclosed. Net loss for the current year period was $132.7 million compared to net income of $12.9 million during the prior year period.

Adjusted EBITDA was $245.0 million for the current year period, a decrease of $9.7 million or 3.8% from the prior year period. A reconciliation of Adjusted EBITDA to net income (loss) as determined in accordance with generally accepted accounting principles for the years ended June 30, 2006 and 2007 is included in the attached supplemental financial information.

The consolidated operating results for the current year period reflect a 2.7% increase in discharges from continuing operations and a 1.5% increase in hospital adjusted discharges from continuing operations compared to the prior year period. Emergency room visits from continuing operations and outpatient surgeries from continuing operations increased 3.4% and 0.2%, respectively, period over period.

Cash flows from operating activities were $123.3 million for the current year period, a decrease of $26.0 million from the prior year period. The decrease was primarily attributable to a $23.2 million growth in net accounts receivable from continuing operations, a $7.1 million reduction in cash flows from discontinued operations and a $6.5 million increase in interest payments during the current year period compared to the prior year period. Cash used in investing activities decreased to $118.5 million during the current year period compared to $245.4 million during the prior year period. The decrease was primarily due to a $111.2 million period over period decrease in capital expenditures from continuing operations as a result of the completion of most of Vanguard's major expansion projects at various times during the current year period.

In June 2007, Vanguard ceased providing acute care services at Phoenix Memorial Hospital ("PMH") and has begun leasing portions of the building to various third party healthcare providers under long-term operating leases. As a result of the change in use of this building, the acute care operations of PMH have been reclassified to discontinued operations for all periods presented. Discontinued operations, as presented in our consolidated statements of operations, now includes the operations of the California hospitals and medical office buildings sold in October 2006 and March 2006, respectively, and the PMH acute care operations.

"Our operating results remain pressured by generally weak demand for inpatient services, intense competition for outpatient services and rising uncompensated care and nursing salaries and benefits costs. We are pleased with the additional patient volumes we are starting to achieve with our recently completed expansion projects in San Antonio and Phoenix but realize that full implementation of these projects may take longer than we initially estimated. We do not expect these challenges to be resolved overnight but we remain committed to our quality of care initiatives that we believe will define our long-term success," commented Charles N. Martin, Jr., Chairman and Chief Executive Officer.

Vanguard will host a conference call for investors at 11:00 am EDT on September 19, 2007. All interested investors are invited to access a live audio broadcast of the call, via webcast. The live webcast can be accessed on the home page of Vanguard's Web site at www.vanguardhealth.com by clicking on "Fourth Quarter Webcast" or at http://visualwebcaster.com/event.asp?id=42019. If you are unable to participate during the live webcast, the call will be available on a replay basis on Vanguard's Web site www.vanguardhealth.com. To access the replay, click on Fourth Quarter Webcast on Vanguard's home page or later on the Latest News link on the Investor Relations page of www.vanguardhealth.com.

Vanguard owns and operates 15 acute care hospitals and complementary facilities and services in Chicago, Illinois; Phoenix, Arizona; San Antonio, Texas and Massachusetts. Vanguard also owns managed health plans in Chicago, Illinois and Phoenix, Arizona and two surgery centers in Orange County, California. Vanguard's strategy is to develop locally branded, comprehensive healthcare delivery networks in urban markets. Vanguard will pursue acquisitions where there are opportunities to partner with leading delivery systems in new urban markets. Upon acquiring a facility or network of facilities, Vanguard implements strategic and operational improvement initiatives including expanding services, strengthening relationships with physicians and managed care organizations, recruiting new physicians and upgrading information systems and other capital equipment. These strategies improve quality and network coverage in a cost effective and accessible manner for the communities Vanguard serves.

This press release contains forward-looking statements within the meaning of the federal securities laws, which are intended to be covered by the safe harbors created thereby. These forward-looking statements include all statements that are not historical statements of fact and those statements regarding Vanguard's intent, belief or expectations. Do not rely on any forward-looking statements as such statements are subject to numerous factors, risks and uncertainties that could cause Vanguard's actual outcomes, results, performance or achievements to be materially different from those projected. These factors, risks and uncertainties include, among others, Vanguard's high degree of leverage and interest rate risk; Vanguard's ability to incur substantially more debt; operating and financial restrictions in Vanguard's debt agreements; Vanguard's ability to successfully implement its business strategies; Vanguard's ability to successfully integrate its recent and any future acquisitions; the highly competitive nature of the healthcare business; governmental regulation of the industry including Medicare and Medicaid reimbursement levels; changes in Federal, state or local regulation affecting the healthcare industry; the possible enactment of Federal or state healthcare reform; pressures to contain costs by managed care organizations and other insurers and Vanguard's ability to negotiate acceptable terms with these third party payers; the ability to attract and retain qualified management and personnel, including physicians and nurses; claims and legal actions relating to professional liabilities or other matters; changes in general economic conditions; Vanguard's exposure to the increased amounts of and collection risks associated with uninsured accounts and the co-pay and deductible portions of insured accounts; Vanguard's ability to maintain or increase patient membership and control costs of its managed healthcare plans; the availability and terms of capital to fund the expansion of Vanguard's business; the geographic concentration of Vanguard's operations; the technological and pharmaceutical improvements that increase the cost of providing healthcare services or reduce the demand for such services; the timeliness of reimbursement payments received under government programs; the potential adverse impact of known and unknown government investigations; and those factors, risks and uncertainties detailed in Vanguard's filings from time to time with the Securities and Exchange Commission, including, among others, Vanguard's Annual Reports on Form 10-K and its Quarterly Reports on Form 10-Q.

Although Vanguard believes that the assumptions underlying the forward-looking statements contained in this press release are reasonable, any of these assumptions could prove to be inaccurate, and, therefore, there can be no assurance that the forward-looking statements included in this press release will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, you should not regard the inclusion of such information as a representation by Vanguard that its objectives and plans anticipated by the forward-looking statements will occur or be achieved, or if any of them do, what impact they will have on Vanguard's results of operations and financial condition. Vanguard undertakes no obligation to publicly release any revisions to any forward-looking statements contained herein to reflect events and circumstances occurring after the date hereof or to reflect the occurrence of unanticipated events.


                     VANGUARD HEALTH SYSTEMS, INC.
           Consolidated Statements of Operations (Unaudited)
                            (In millions)

                                            Three months ended
                                                  June 30,
                                  ---------------------------------------
                                         2006                   2007
                                  ---------------------------------------

Patient service revenues          $521.0     83.8%         $545.8    83.8%
Premium revenues                   100.8     16.2           105.3    16.2
                                  ---------------------------------------

Total revenues                     621.8    100.0           651.1   100.0

Costs and expenses:
  Salaries and benefits
   (includes stock compensation
   of $0.6 and $0.5, respectively) 253.6     40.8           271.3    41.7
  Supplies                         101.2     16.3           108.4    16.6
  Medical claims expense            73.6     11.8            76.7    11.8
  Provision for doubtful accounts   37.1      6.0            45.7     7.0
  Purchased services                35.6      5.7            32.3     4.9
  Rents and leases                   9.1      1.5             9.6     1.5
  Other operating expenses          54.0      8.7            49.4     7.6
  Depreciation and amortization     30.9      4.9            32.3     5.0
  Interest, net                     26.7      4.3            31.1     4.8
  Other expenses                     4.6      0.7             1.6     0.2
                                  ---------------------------------------

       Total costs and expenses    626.4    100.7           658.4   101.1
                                  ---------------------------------------

Loss from continuing operations
 before income taxes                (4.6)    (0.7)           (7.3)   (1.1)
Income tax benefit                  (2.1)    (0.3)           (1.7)   (0.3)
                                  ---------------------------------------

Loss from continuing operations     (2.5)    (0.4)           (5.6)   (0.8)
Loss from discontinued operations,
 net of taxes                      (11.1)    (1.8)           (4.0)   (0.6)
                                  ---------------------------------------

Net loss                          $(13.6)    (2.2)%        $ (9.6)   (1.4)%
                                  ======                   ======





                        VANGUARD HEALTH SYSTEMS, INC.
                    Consolidated Statements of Operations
                                (In millions)

                                                 Year ended
                                                  June 30,
                                  ---------------------------------------
                                         2006                   2007
                                  ---------------------------------------

Patient service revenues          $2,043.6   84.5%       $2,179.3    84.4%
Premium revenues                     375.0   15.5           401.4    15.6
                                  ---------------------------------------

Total revenues                     2,418.6  100.0         2,580.7   100.0

Costs and expenses:
  Salaries and benefits
   (includes stock compensation
   of $1.7 and $1.2, respectively)   991.4   41.0         1,067.9    41.4
  Supplies                           394.1   16.3           421.8    16.3
  Medical claims expense             270.3   11.2           297.0    11.5
  Provision for doubtful accounts    156.8    6.5           175.2     6.8
  Purchased services                 128.1    5.3           141.2     5.5
  Rents and leases                    33.9    1.4            37.4     1.4
  Other operating expenses           191.0    7.9           196.4     7.6
  Depreciation and amortization      100.3    4.1           118.6     4.6
  Interest, net                      103.8    4.3           123.8     4.8
  Debt extinguishment costs            0.1    0.0               -     0.0
  Impairment loss                        -    0.0           123.8     4.8
  Other expenses                       9.1    0.4             2.8     0.1
                                  ---------------------------------------

    Total costs and expenses       2,378.9   98.4         2,705.9   104.9
                                  ---------------------------------------

Income (loss) from continuing
 operations before income taxes       39.7    1.6          (125.2)   (4.8)
Income tax expense (benefit)          16.2    0.6           (11.6)   (0.4)
                                  ---------------------------------------

Income (loss) from continuing
 operations                           23.5    0.9          (113.6)   (4.4)
Loss from discontinued operations,
 net of taxes                        (10.6)  (0.4)          (19.1)   (0.7)
                                  ---------------------------------------

Net income (loss)                 $   12.9    0.5%       $ (132.7)   (5.1)%
                                  ======                   ======




                          VANGUARD HEALTH SYSTEMS, INC.
                  Supplemental Financial Information (Unaudited)
               Reconciliation of Adjusted EBITDA to Net Income (Loss)
                                  (In millions)


                             Three months ended          Year ended
                                  June 30,                 June 30,
                            -------------------      --------------------
                              2006        2007         2006        2007
                            -------     -------      -------      -------

Net income (loss)           $ (13.6)    $  (9.6)     $  12.9      $(132.7)
Interest, net                  26.7        31.1        103.8        123.8
Income tax expense (benefit)   (2.1)       (1.7)        16.2        (11.6)
Depreciation and amortization  30.9        32.3        100.3        118.6
Minority interests              0.2         0.6          2.6          2.6
Loss (gain) on disposal of
 assets                         2.5        (0.2)         1.5         (4.1)
Equity method loss (income)     0.6        (0.1)        (0.2)        (0.9)
Stock compensation              0.6         0.5          1.7          1.2
Debt extinguishment costs         -           -          0.1            -
Monitoring fees                 1.3         1.3          5.2          5.2
Impairment loss                   -           -            -        123.8
Discontinued operations,
 net of taxes                  11.1         4.0         10.6         19.1
                            -------     -------      -------      -------
     Adjusted EBITDA (a)    $  58.2     $  58.2      $ 254.7      $ 245.0
                            =======     =======      =======      =======


(a) Adjusted EBITDA is defined as income before interest expense (net of
    interest income), income taxes, depreciation and amortization,
    minority interests, gain or loss on the disposal of assets, equity
    method income or loss, stock compensation, debt extinguishment costs,
    merger expenses, monitoring fees, impairment loss and discontinued
    operations, net of taxes.  Adjusted EBITDA is not intended as a
    substitute for net income, operating cash flows or other cash flow
    statement data determined in accordance with accounting principles
    generally accepted in the United States.  Due to varying methods of
    calculation, Adjusted EBITDA as presented may not be comparable to
    similarly titled measures of other companies.




                        VANGUARD HEALTH SYSTEMS, INC.
                         Consolidated Balance Sheets
                                (In millions)


                                          June 30,            June 30,
                                            2006                2007
                                          ----------------------------
                    ASSETS
Current assets:
    Cash and cash equivalents             $  123.6            $  120.1
    Restricted cash                              -                 6.2
    Accounts receivable, net of
     allowance for uncollectible accounts
     of approximately $103.5 and $113.2
     at June 30, 2006 and 2007,
     respectively                            294.1               287.3
    Inventories                               45.3                46.8
    Assets held for sale                      52.1                   -
    Prepaid expenses and other current
     assets                                   45.9                57.7
                                          --------            --------

        Total current assets                 561.0               518.1

Property, plant and equipment, net of
 accumulated depreciation                  1,159.5             1,186.6
Goodwill                                     812.8               689.2
Intangible assets, net of accumulated
 amortization                                 69.0                68.0
Investments in and advances to affiliates      8.2                 7.3
Other assets                                  40.0                62.2
                                          --------            --------

        Total assets                      $2,650.5            $2,531.4
                                          ========            ========

    LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
    Accounts payable                      $  151.8            $  144.1
    Accrued salaries and benefits             78.5                75.0
    Accrued health claims                     44.0                57.2
    Accrued interest                          13.3                13.4
    Other accrued expenses and current
     liabilities                              72.1                64.0
    Current maturities of long-term debt       8.3                 8.0
                                          --------            --------

        Total current liabilities            368.0               361.7
Minority interests in equity of
 consolidated entities                         9.4                 9.3
Other liabilities                             73.0                82.3
Long-term debt, less current maturities    1,510.9             1,520.7
Commitments and contingencies

Stockholders' equity:
Common Stock                                     -                   -
Additional paid-in capital                   643.7               644.6
Retained earnings (deficit)                   45.5               (87.2)
                                          --------            --------

        Total liabilities and
         stockholders' equity             $2,650.5            $2,531.4
                                          ========            ========




                      VANGUARD HEALTH SYSTEMS, INC.
                 Consolidated Statements of Cash Flows
                             (In millions)


                                                           Year ended
                                                             June 30,
                                                        ------------------
                                                          2006      2007
                                                        --------  --------
Operating activities:
Net income (loss)                                       $   12.9  $ (132.7)
Adjustments to reconcile net income (loss) to net cash
 from operating activities:
   Loss from discontinued operations                        10.6      19.1
   Depreciation and amortization                           100.3     118.6
   Provision for doubtful accounts                         156.8     175.2
   Deferred income taxes                                     8.5     (12.7)
   Amortization of loan costs                                4.0       4.5
   Accretion of principal on senior discount notes          15.7      17.5
   Loss (gain) on disposal of assets                         1.5      (4.1)
   Stock compensation                                        1.7       1.2
   Debt extinguishment costs                                 0.1         -
   Impairment loss                                             -     123.8
   Changes in operating assets and liabilities from
    continuing operations:
     Accounts receivable                                  (162.4)   (204.0)
     Inventories                                            (5.2)     (1.9)
     Prepaid expenses and other current assets               3.6     (23.3)
     Accounts payable                                        2.4       7.4
     Accrued expenses and other liabilities                (11.9)     31.1
                                                        --------  --------
Net cash provided by operating activities -
 continuing operations                                     138.6     119.7
Net cash provided by operating activities -
 discontinued operations                                    10.7       3.6
                                                        --------  --------
Net cash provided by operating activities                  149.3     123.3

Investing activities:
Acquisitions, including working capital settlement
 payments                                                   (1.2)     (0.2)
Capital expenditures                                      (275.5)   (164.3)
Proceeds from asset sales                                   11.1       9.5
Purchases of short-term investments                       (128.4)   (120.0)
Sales of short-term investments                            128.4     120.0
Other                                                        0.6       2.0
                                                        --------  --------
Net cash used in investing activities -
 continuing operations                                    (265.0)   (153.0)
Net cash provided by investing activities -
 discontinued operations                                    19.6      34.5
                                                        --------  --------
Net cash used in investing activities                     (245.4)   (118.5)

Financing activities:
Proceeds from long-term debt                               175.0         -
Payments of long-term debt and capital leases              (31.4)     (8.0)
Payments to retire common stock and equity incentive
 units                                                      (2.5)     (0.5)
Other                                                       (0.6)      0.2
                                                        --------  --------
Net cash provided by (used in) financing activities        140.5      (8.3)
                                                        --------  --------
Net increase (decrease) in cash and cash equivalents        44.4      (3.5)
Cash and cash equivalents, beginning of period              79.2     123.6
                                                        --------  --------
Cash and cash equivalents, end of period                $  123.6  $  120.1
                                                        ========  ========
Net cash paid for interest                              $  101.3  $  107.8
                                                        ========  ========
Net cash paid for income taxes                          $    2.1  $    0.9
                                                        ========  ========




                    VANGUARD HEALTH SYSTEMS, INC.
         Selected Operating Statistics - Continuing Operations
                            (Unaudited)


                                               Three months ended
                                                    June 30,
                                                 -------------------------
                                                  2006     2007  % Change
                                                 -------  ------- -------

Number of hospitals at end of period                  15       15
Licensed beds at end of period                     3,937    4,143
Discharges                                        40,667   41,497     2.0%
Adjusted discharges-hospitals                     65,612   66,690     1.6%
Average length of stay                              4.27     4.31     0.9%
Patient days                                     173,571  179,006     3.1%
Adjusted patient days-hospitals                  280,038  287,680     2.7%
Patient revenue per adjusted
 discharge-hospitals                            $  7,448 $  7,817     5.0%
Outpatient surgeries                              19,428   19,271    (0.8)%
Emergency room visits                            138,815  142,987     3.0%

Charity care as a percent of patient
 service revenues                                    3.5%     3.6%

Provision for doubtful accounts as a percent
 of patient service revenues                         7.1%     8.4%

Net patient revenue payer mix:
   Medicare                                         27.9%    27.2%
   Medicaid                                          6.9%     7.0%
   Managed care                                     52.5%    54.0%
   Commercial                                        4.0%     1.3%
   Self-pay                                          8.7%    10.5%
                                                 -------  -------
      Total                                        100.0%   100.0%
                                                 =======  =======




                     VANGUARD HEALTH SYSTEMS, INC.
        Selected Operating Statistics - Continuing Operations
                             (Unaudited)

                                               Year ended
                                                June 30,
                                           -------------------------------
                                             2006       2007     % Change
                                           ---------  ---------  ---------

Number of hospitals at end of period              15         15
Licensed beds at end of period                 3,937      4,143
Discharges                                   162,446    166,873        2.7%
Adjusted discharges-hospitals                261,422    265,448        1.5%
Average length of stay                          4.32       4.33        0.2%
Patient days                                 701,307    721,832        2.9%
Adjusted patient days-hospitals            1,128,603  1,148,233        1.7%
Patient revenue per adjusted
 discharge-hospitals                       $   7,332  $   7,798        6.4%
Outpatient surgeries                          76,437     76,606        0.2%
Emergency room visits                        554,250    572,946        3.4%

Charity care as a percent of patient
 service revenues                                3.5%       4.0%

Provision for doubtful accounts as a
 percent of patient service revenues             7.7%       8.0%

Net patient revenue payer mix:
   Medicare                                     28.2%      26.4%
   Medicaid                                      7.1%       8.6%
   Managed care                                 51.2%      52.3%
   Commercial                                    4.3%       3.0%
   Self-pay                                      9.2%       9.7%
                                           ---------  ---------
      Total                                    100.0%     100.0%
                                           =========  =========

Contact Information

  • Contact:
    Vanguard Health Systems, Inc.
    Aaron Broad
    Director Investor Relations
    (615) 665-6131